The pharmaceutical industry not only contributes to human health but is also growing in importance for Sweden as an export country. According to Statistics Sweden, pharmaceuticals were exported in the first half of 2022 to a value of SEK 70 billion and pharmaceuticals account for 7.1% of Sweden's total exports. As a country, we repeatedly stand out as a country of innovation in international rankings. The pharmaceutical industry thus has great potential to contribute to Swedish economic prosperity in a declining economy.
SwedenBIO, in collaboration with AstraZeneca, Pfizer, Novavax, Recipharm, APL, Valneva, NorthX Biologics, Phase2Phase Biopharma and Mpya Sci & Tech , is organizing a half-day conference with pharmaceutical manufacturing in focus.
This is a meeting aimed at policy makers and a way for the industry to reach out for deeper collaboration, new perspectives and increased knowledge. The program runs from 13:00-17:00, followed by a mingle until 18:30.
Read more and register here.
